Kidney Function Test Market Overview
Kidneys are regarded as one of the most vital organs that act as blood filters and reabsorb essential elements while removing water-soluble waste products from the blood. Since kidneys play a significant role, they require constant regeneration to aid maintenance of healthy cell growth.
Kidney function damage is surprisingly common across the globe, and it is proliferating speedily. The Market Research Future (MRFR) report suggests that the global kidney function test market is expected to inflate at a 5.7% CAGR through the assessment period.
Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6171
Key Players
The global kidney function test market showcases the presence of many influential players during the assessment period. MRFR sheds light on the profiles of some of these principal players including
- Urit Medical
- Siemens Healthcare GmbH (Germany)
- Opti Medical
- Randox Laboratories
- Sysmex Corporation
- Nova Biomedical
- Hoffmann-La Roche Ltd
- Beckman Coulter
- Acon Laboratories
- Abbott
- 77 Elektronika
- ARKRAY Inc.
- Medical Care (Germany)
- Baxter (U.S.) and Boston Scientific (U.S.).
- Detailed Regional Analysis and Drivers
Market Segmentation
The global kidney functioning test market has been analyzed for different segments based on tests, products, and end-users.
By category, the segments include blood tests, imaging tests, urine test balloons, and kidney biopsy. The blood test segment is sub-segmented into serum creatinine, blood urea nitrogen (BUN), and glomerular filtration rate (GFR). The imaging tests segment includes the sub-segments of ultrasound and CT scan. The urine tests segment is further segmented into urinalysis, microalbuminuria, creatinine clearance, and urine protein.
Based on product, the global kidney function test market is segmented into dipsticks, disposables, and reagents.
Based on end-user, the market segments for kidney function tests include hospitals, clinics, diagnostic laboratories, academic research laboratories, and ambulatory surgical centers.
Inquire for an Amazing Dioscount on https://www.marketresearchfuture.com/check-discount/6171
Regional Market Summary
The MRFR report is studied for various regional segments of the global kidney function test market. These segments include North America, South America, Asia Pacific, Europe, and the Middle East & Africa.
North America and South America are likely to dictate the global kidney function market during the forecast period. A rise in the occurrence of chronic kidney diseases is estimated to push the market to a great extent. As per the Centers of Disease Control and Prevention (2017), 30 million Americans were affected by Chronic Kidney Disease. It also mentions that women are more prone to chronic kidney diseases than men.
Europe’s market for kidney function test is studied for the U.K., Belgium, France, and the Netherlands. Europe is expected to garner the second largest share for kidney function test market. One of the accreditable factors includes the rising prevalence of diabetes and growth in healthcare expenditure. World Health Organization, in 2015, stated that 60 million people in Europe were affected by diabetes. Hence, a high prevalence of diabetes is anticipated to be the primary driver of the kidney function test market in Europe.
Asia Pacific is projected to showcase significant growth in the kidney function test market due to a rising prevalence of diabetes, proliferating geriatric population, high prevalence of hypertension, and a shift to an unhealthy lifestyle. As per the Blood Pressure Association, in 2015, South Asia had 226 million people in China and 199 million in India with high blood pressure. High blood pressure damages the blood vessels of the kidney, leading to improper functioning of the kidney. This, is hence, contributing exponentially to the market growth for kidney functioning tests.
Browse Complete Premium Research Report at https://www.marketresearchfuture.com/reports/kidney-function-test-market-6171
Industry News
April 2019: Merck announced that the U.S. Food and Drug Administration had approved KEYTRUDA. KEYTRUDA is an anti-PD-1 therapy, which in combination with Inlyta (axitinib), a kinase inhibitor, aids in the treatment of patients having advanced renal cell carcinoma (RCC).
About Market Research Future: Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Your information will never be shared with any third party.